
First empirical evidence to show that individualised tDCS dose is associated with greater improvement compared to fixed dosage. Specifically, non responders in fixed dosage converts to responders. The sex difference in fixed dose gets neutralized in individualised dosage.
Rajan Kashyap@Rajankashya
Our latest study with @SagarikaBhatta & co from @NIMHANS_BLR @NTUsg @JohnHopkinsUn . It is possibly the #first personalised #tdcs study and shows the benefits of converting non-responders to responders of treatment. Era of #precisionmedicine starts with funding from @DBTIndia
English

















